Labcorp stock heads into the open after a muted move

At the close on September 11, 2026, Labcorp stock finished the NYSE session near the USD 311 mark with a modest single-digit percent change, while broader US indices advanced. Dividend details from recent weeks still frame the shares ahead of today’s session.

Labcorp stock closed near USD 311 on the New York Stock Exchange on September 11, 2026, marking a modest single-digit percent move versus the prior session’s close. In the same session, major US equity benchmarks such as the S&P 500 advanced, so Labcorp lagged a generally positive market backdrop.

September 11, 2026 in numbers

Labcorp Holdings Inc. (ISIN US50540R4092) ended trading on the NYSE on September 11, 2026 with a closing price around USD 311 per share, within its intraday range between the day’s low and high and inside its prevailing 52-week corridor. Per recent quote commentary on Labcorp, the shares had declined by roughly 4.3 percent in an earlier session before stabilizing near the current level, underscoring that the stock remains below recent highs but above its recent lows as the week progresses.MarketBeat noted that Labcorp opened at USD 311.36 on Friday in its latest coverage, placing the closing level well above the recent low that followed the 4.3 percent slide.

According to the same report from MarketBeat, Labcorp recently exceeded quarterly earnings expectations with earnings per share of USD 4.99 on revenue of USD 3.73 billion and reaffirmed its adjusted EPS guidance range of USD 18.10 to USD 18.55 for the 2026 financial year. The same coverage highlighted that a quarterly dividend of USD 0.72 per share was paid on September 11, 2026 to shareholders of record as of August 28, 2026, meaning the September 11 session captured the stock trading on the dividend payment date.

Today’s factors for Labcorp

As of today, September 14, 2026, Labcorp’s reaffirmed full-year 2026 adjusted EPS guidance and the recent positive earnings surprise remain central reference points for investors, particularly in light of the prior 4.3 percent share-price decline reported in recent trading commentary.MarketBeat emphasized that analysts expect Labcorp to post about USD 18.32 in EPS for the current year, which keeps attention on how upcoming quarters track against the guidance range. Broader US macro data and sector developments in healthcare and diagnostics may also shape sentiment toward Labcorp today, given the stock’s recent underperformance versus the advancing US indices on September 11, 2026.